AIMV.US AI Maverick Intel Inc.

Healthcare Medical Devices USA Stocks
0.0740 USD
Close of Nov 14, 2026
0.0126 0.2900
Market cap
USD 9.58M
P/E
-
P/B
-
ROE
-28.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is AIMV.US undervalued?

Graham number

The Graham number of AI Maverick Intel Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

AI Maverick Intel Inc. fundamental analysis

No fundamental analysis for AI Maverick Intel Inc. yet.

AI Maverick Intel Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About AI Maverick Intel Inc.

AI Maverick Intel, Inc., an AI company, focuses on acquiring and enhancing businesses through its proprietary AI Maverick platform. Its technology streamlines the customer acquisition process by automating two way communication and data-driven engagement with its clients ideal audience segments across healthcare, biotech, and other sectors. The company was formerly known as Bionoid Pharma Inc. and changed its name to AI Maverick Intel, Inc. in April 2025. AI Maverick Intel, …

Full company profile